NCT06240403View on ClinicalTrials.gov

Digoxin and Senolysis in Heart Failure and Diabetes Mellitus

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 28, 2028

Study Completion Date

August 28, 2029

Conditions
Heart Failure, SystolicDiabetes Mellitus, Type 2
Interventions
DRUG

Digoxin 0.125 MG

One capsule containing digoxin per day for three months

Trial Locations (1)

LS16 5AR

Leeds Teaching Hospitals NHS Trust, Leeds

All Listed Sponsors
lead

University of Leeds

OTHER